Functional analysis of C-TAK1 substrate binding and identification of PKP2 as a new C-TAK1 substrate

Jürgen Müller1, Daniel A Ritt, Terry D Copeland

  • 1Regulation of Cell Growth Laboratory, Center for Cancer Research, NCI-Frederick, PO Box B, Frederick, MD 21702, USA.

The EMBO Journal
|August 28, 2003
PubMed

Insights

Cdc25C-associated kinase 1 (C-TAK1) regulates cell signaling by creating 14-3-3-binding sites on substrates like KSR1 and Cdc25C. This impacts protein localization and biological activity, highlighting C-TAK1

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Cdc25C-associated kinase 1 (C-TAK1) is involved in cell cycle regulation and Ras signaling.
  • C-TAK1 interacts with Cdc25C phosphatase and KSR1, a MAPK scaffold protein.

Purpose of the Study:

  • To identify sequence motifs essential for C-TAK1 binding and substrate phosphorylation.
  • To investigate the role of C-TAK1 in regulating KSR1 and Cdc25C through 14-3-3-binding site generation.
  • To identify novel C-TAK1 substrates and their regulation.

Main Methods:

  • Mutational analysis to disrupt C-TAK1 binding to KSR1 and Cdc25C.
  • In vivo phosphorylation assays to assess 14-3-3-binding site generation.
  • Identification of plakophilin 2 (PKP2) as a novel C-TAK1 substrate.

Main Results:

  • Disruption of C-TAK1 binding reduced 14-3-3-binding site phosphorylation in KSR1 and Cdc25C.
  • KSR1 mutants showed constitutive plasma membrane localization and increased activity.
  • Cdc25C mutants accumulated in the nucleus.
  • PKP2 was identified as a novel substrate, with C-TAK1 phosphorylation creating a 14-3-3-binding site influencing its localization.

Conclusions:

  • C-TAK1 is crucial for regulating 14-3-3 binding and protein localization.
  • C-TAK1-mediated phosphorylation controls the cellular distribution and activity of key signaling proteins.
  • The study identifies PKP2 as a new substrate, expanding the known functions of C-TAK1.

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Enzymes02:34

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...